Consort Medical plc (NASDAQ:CSRMY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday.

According to Zacks, “Consort Medical Plc engages in the design, development, manufacture and sale of medical drug delivery devices. It operates through the Bespak and Aesica segments. Bespak segment develops and produces drug delivery devices which serves pharmaceutical companies with inhaler and auto-injector technologies. Aesica segment is a contract development and manufacturing organization which serves pharmaceutical firms with active pharmaceutical ingredient and finished dose formulation development and manufacturing services. Consort Medical Plc is headquartered in Hemel Hempstead, United Kingdom. “

Shares of Consort Medical plc (NASDAQ CSRMY) remained flat at $15.00 during trading on Tuesday. The company’s 50 day moving average price is $14.49 and its 200 day moving average price is $13.59. Consort Medical plc has a 1-year low of $12.90 and a 1-year high of $15.00. The firm has a market capitalization of $733.70 million and a P/E ratio of 24.83.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/consort-medical-plc-csrmy-stock-rating-lowered-by-zacks-investment-research/1492176.html.

About Consort Medical plc

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.

Get a free copy of the Zacks research report on Consort Medical plc (CSRMY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with Analyst Ratings Network's FREE daily email newsletter.